aluates Reports

$ 0.0

Global BCMA-targeted CAR-T Cell Therapy Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-4R18741

Global BCMA targeted CAR T Cell Therapy Market Research Report 2024

BUY CHAPTERS

Global BCMA-targeted CAR-T Cell Therapy Market Research Report 2025

Code: QYRE-Auto-4R18741

Report

March 2025

Pages:65

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CARsgen

Bristol-Myers Squibb (Abecma)

Nanjing Iaso Biotherapeutics

Nanjing Legend Biotechnology/J&J (Carvykti)

BCMA-targeted CAR-T Cell Therapy Market Size

The global market for BCMA-targeted CAR-T Cell Therapy was valued at US$ 1381 million in the year 2024 and is projected to reach a revised size of US$ 6878 million by 2031, growing at a CAGR of 25.0% during the forecast period.

BCMA-targeted CAR-T Cell Therapy Market

Chimeric antigen receptor (CAR) T-cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. Currently available CAR-T cell therapy products are divided into CD19 targets and BCMA targets. BCMA stands for B - cell maturation antigen. It is a protein that is found on the surface of plasma cells, which are abnormal cells that multiply uncontrollably in multiple myeloma, a type of blood cancer. By targeting BCMA, the CAR - T cell therapy aims to specifically attack the cancer - causing plasma cells.

Major players: The BCMA-targeted CAR-T cell therapy market presents a highly concentrated duopoly. In 2024, the global market CR2 index exceeded 98%. The main products are Carvykti (Cedacion) jointly developed by Legend Biotech and Johnson & Johnson and Abecma of Bristol-Myers Squibb. Among them, Carvykti continues to expand its market leadership with significant clinical advantages, and its global sales in 2024 increased by 93% year-on-year. In contrast, Abecma's sales in the current period decreased by about 14% year-on-year due to intensified market competition and product iteration pressure.

Market Trends: The BCMA CAR - T cell therapy market is in a phase of rapid growth. The reasons for this growth are two - fold. Firstly, there is a large population of patients with multiple myeloma, and there are many unmet medical needs. Secondly, this therapy has demonstrated good efficacy and has been recognized by the market. With the maturation of technology and market promotion, it is expected that the market will maintain a high growth rate in the coming years.

Expansion of Indications: Currently, BCMA CAR - T cell therapy is mainly used for the treatment of relapsed or refractory multiple myeloma. With the deepening of research, its indications are expected to be broadened. Pre - clinical and clinical trials are exploring its application in other hematological malignancies, such as certain types of leukemia and lymphoma. If successful, this will greatly expand the market size, bring hope to more patients, and inject new impetus into the growth of the therapy market.

Changing Competitive Landscape：The market competition is becoming increasingly fierce. In addition to the already - launched products such as Ciltacabtagene Autoleucel (Carvykti) and Idecabtagene Vicleucel (Abecma), many pharmaceutical companies are actively deploying and researching BCMA CAR - T products. New entrants may change the existing competitive landscape with innovative technologies or better cost control.

High - Cost Constraints: The research, development, and production processes of BCMA CAR - T cell therapy are complex, involving multiple high - cost links such as cell collection, gene editing, and cell culture, resulting in high product prices. This makes it difficult for many patients to afford, limiting the accessibility of the therapy and, to a certain extent, hindering the rapid expansion of the market. How to reduce costs so that more patients can benefit is an important challenge faced by the entire industry.

Safety Risks：Although this therapy has achieved remarkable results in clinical applications, there are still certain safety risks, such as cytokine release syndrome (CRS) and neurotoxicity. These adverse reactions may have a serious impact on the health of patients and even endanger their lives.

This report aims to provide a comprehensive presentation of the global market for BCMA-targeted CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCMA-targeted CAR-T Cell Therapy.

The BCMA-targeted CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BCMA-targeted CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the BCMA-targeted CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of BCMA-targeted CAR-T Cell Therapy Market Report

Report Metric	Details
Report Name	BCMA-targeted CAR-T Cell Therapy Market
Accounted market size in year	US$ 1381 million
Forecasted market size in 2031	US$ 6878 million
CAGR	25.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Abecma Carvykti Others
Segment by Application	Hospital Oncology Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nanjing Legend Biotechnology/J&J (Carvykti), Bristol-Myers Squibb (Abecma), CARsgen, Nanjing Iaso Biotherapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BCMA-targeted CAR-T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is BCMA-targeted CAR-T Cell Therapy Market growing?

Ans: The BCMA-targeted CAR-T Cell Therapy Market witnessing a CAGR of 25.0% during the forecast period 2025-2031.

What is the BCMA-targeted CAR-T Cell Therapy Market size in 2031?

Ans: The BCMA-targeted CAR-T Cell Therapy Market size in 2031 will be US$ 6878 million.

What is the BCMA-targeted CAR-T Cell Therapy Market share by type?

Ans: Among them, Carvykti continues to expand its market leadership with significant clinical advantages, and its global sales in 2024 increased by 93% year-on-year. In contrast, Abecma's sales in the current period decreased by about 14% year-on-year due to intensified market competition and product iteration pressure.

Who are the main players in the BCMA-targeted CAR-T Cell Therapy Market report?

Ans: The main players in the BCMA-targeted CAR-T Cell Therapy Market are Nanjing Legend Biotechnology/J&J (Carvykti), Bristol-Myers Squibb (Abecma), CARsgen, Nanjing Iaso Biotherapeutics

What are the Application segmentation covered in the BCMA-targeted CAR-T Cell Therapy Market report?

Ans: The Applications covered in the BCMA-targeted CAR-T Cell Therapy Market report are Hospital, Oncology Clinic

What are the Type segmentation covered in the BCMA-targeted CAR-T Cell Therapy Market report?

Ans: The Types covered in the BCMA-targeted CAR-T Cell Therapy Market report are Abecma, Carvykti, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Abecma

1.2.3 Carvykti

1.2.4 Others

1.3 Market by Application

1.3.1 Global BCMA-targeted CAR-T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Oncology Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global BCMA-targeted CAR-T Cell Therapy Market Perspective (2020-2031)

2.2 Global BCMA-targeted CAR-T Cell Therapy Growth Trends by Region

2.2.1 Global BCMA-targeted CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 BCMA-targeted CAR-T Cell Therapy Historic Market Size by Region (2020-2025)

2.2.3 BCMA-targeted CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031)

2.3 BCMA-targeted CAR-T Cell Therapy Market Dynamics

2.3.1 BCMA-targeted CAR-T Cell Therapy Industry Trends

2.3.2 BCMA-targeted CAR-T Cell Therapy Market Drivers

2.3.3 BCMA-targeted CAR-T Cell Therapy Market Challenges

2.3.4 BCMA-targeted CAR-T Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top BCMA-targeted CAR-T Cell Therapy Players by Revenue

3.1.1 Global Top BCMA-targeted CAR-T Cell Therapy Players by Revenue (2020-2025)

3.1.2 Global BCMA-targeted CAR-T Cell Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top BCMA-targeted CAR-T Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by BCMA-targeted CAR-T Cell Therapy Revenue

3.4 Global BCMA-targeted CAR-T Cell Therapy Market Concentration Ratio

3.4.1 Global BCMA-targeted CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by BCMA-targeted CAR-T Cell Therapy Revenue in 2024

3.5 Global Key Players of BCMA-targeted CAR-T Cell Therapy Head office and Area Served

3.6 Global Key Players of BCMA-targeted CAR-T Cell Therapy, Product and Application

3.7 Global Key Players of BCMA-targeted CAR-T Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 BCMA-targeted CAR-T Cell Therapy Breakdown Data by Type

4.1 Global BCMA-targeted CAR-T Cell Therapy Historic Market Size by Type (2020-2025)

4.2 Global BCMA-targeted CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031)

5 BCMA-targeted CAR-T Cell Therapy Breakdown Data by Application

5.1 Global BCMA-targeted CAR-T Cell Therapy Historic Market Size by Application (2020-2025)

5.2 Global BCMA-targeted CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America BCMA-targeted CAR-T Cell Therapy Market Size (2020-2031)

6.2 North America BCMA-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025)

6.4 North America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe BCMA-targeted CAR-T Cell Therapy Market Size (2020-2031)

7.2 Europe BCMA-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025)

7.4 Europe BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size (2020-2031)

8.2 Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America BCMA-targeted CAR-T Cell Therapy Market Size (2020-2031)

9.2 Latin America BCMA-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025)

9.4 Latin America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size (2020-2031)

10.2 Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nanjing Legend Biotechnology/J&J (Carvykti)

11.1.1 Nanjing Legend Biotechnology/J&J (Carvykti) Company Details

11.1.2 Nanjing Legend Biotechnology/J&J (Carvykti) Business Overview

11.1.3 Nanjing Legend Biotechnology/J&J (Carvykti) BCMA-targeted CAR-T Cell Therapy Introduction

11.1.4 Nanjing Legend Biotechnology/J&J (Carvykti) Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

11.1.5 Nanjing Legend Biotechnology/J&J (Carvykti) Recent Development

11.2 Bristol-Myers Squibb (Abecma)

11.2.1 Bristol-Myers Squibb (Abecma) Company Details

11.2.2 Bristol-Myers Squibb (Abecma) Business Overview

11.2.3 Bristol-Myers Squibb (Abecma) BCMA-targeted CAR-T Cell Therapy Introduction

11.2.4 Bristol-Myers Squibb (Abecma) Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

11.2.5 Bristol-Myers Squibb (Abecma) Recent Development

11.3 CARsgen

11.3.1 CARsgen Company Details

11.3.2 CARsgen Business Overview

11.3.3 CARsgen BCMA-targeted CAR-T Cell Therapy Introduction

11.3.4 CARsgen Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

11.3.5 CARsgen Recent Development

11.4 Nanjing Iaso Biotherapeutics

11.4.1 Nanjing Iaso Biotherapeutics Company Details

11.4.2 Nanjing Iaso Biotherapeutics Business Overview

11.4.3 Nanjing Iaso Biotherapeutics BCMA-targeted CAR-T Cell Therapy Introduction

11.4.4 Nanjing Iaso Biotherapeutics Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

11.4.5 Nanjing Iaso Biotherapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CARsgen

Bristol-Myers Squibb (Abecma)

Nanjing Iaso Biotherapeutics

Nanjing Legend Biotechnology/J&J (Carvykti)

List of Tables

Table 1. Global BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Abecma

Table 3. Key Players of Carvykti

Table 4. Key Players of Others

Table 5. Global BCMA-targeted CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global BCMA-targeted CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global BCMA-targeted CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global BCMA-targeted CAR-T Cell Therapy Market Share by Region (2020-2025)

Table 9. Global BCMA-targeted CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global BCMA-targeted CAR-T Cell Therapy Market Share by Region (2026-2031)

Table 11. BCMA-targeted CAR-T Cell Therapy Market Trends

Table 12. BCMA-targeted CAR-T Cell Therapy Market Drivers

Table 13. BCMA-targeted CAR-T Cell Therapy Market Challenges

Table 14. BCMA-targeted CAR-T Cell Therapy Market Restraints

Table 15. Global BCMA-targeted CAR-T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global BCMA-targeted CAR-T Cell Therapy Market Share by Players (2020-2025)

Table 17. Global Top BCMA-targeted CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCMA-targeted CAR-T Cell Therapy as of 2024)

Table 18. Ranking of Global Top BCMA-targeted CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by BCMA-targeted CAR-T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of BCMA-targeted CAR-T Cell Therapy, Headquarters and Area Served

Table 21. Global Key Players of BCMA-targeted CAR-T Cell Therapy, Product and Application

Table 22. Global Key Players of BCMA-targeted CAR-T Cell Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global BCMA-targeted CAR-T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global BCMA-targeted CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global BCMA-targeted CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global BCMA-targeted CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global BCMA-targeted CAR-T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global BCMA-targeted CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global BCMA-targeted CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global BCMA-targeted CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Nanjing Legend Biotechnology/J&J (Carvykti) Company Details

Table 48. Nanjing Legend Biotechnology/J&J (Carvykti) Business Overview

Table 49. Nanjing Legend Biotechnology/J&J (Carvykti) BCMA-targeted CAR-T Cell Therapy Product

Table 50. Nanjing Legend Biotechnology/J&J (Carvykti) Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 51. Nanjing Legend Biotechnology/J&J (Carvykti) Recent Development

Table 52. Bristol-Myers Squibb (Abecma) Company Details

Table 53. Bristol-Myers Squibb (Abecma) Business Overview

Table 54. Bristol-Myers Squibb (Abecma) BCMA-targeted CAR-T Cell Therapy Product

Table 55. Bristol-Myers Squibb (Abecma) Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 56. Bristol-Myers Squibb (Abecma) Recent Development

Table 57. CARsgen Company Details

Table 58. CARsgen Business Overview

Table 59. CARsgen BCMA-targeted CAR-T Cell Therapy Product

Table 60. CARsgen Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 61. CARsgen Recent Development

Table 62. Nanjing Iaso Biotherapeutics Company Details

Table 63. Nanjing Iaso Biotherapeutics Business Overview

Table 64. Nanjing Iaso Biotherapeutics BCMA-targeted CAR-T Cell Therapy Product

Table 65. Nanjing Iaso Biotherapeutics Revenue in BCMA-targeted CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 66. Nanjing Iaso Biotherapeutics Recent Development

Table 67. Research Programs/Design for This Report

Table 68. Key Data Information from Secondary Sources

Table 69. Key Data Information from Primary Sources

Table 70. Authors List of This Report

List of Figures

Figure 1. BCMA-targeted CAR-T Cell Therapy Picture

Figure 2. Global BCMA-targeted CAR-T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global BCMA-targeted CAR-T Cell Therapy Market Share by Type: 2024 VS 2031

Figure 4. Abecma Features

Figure 5. Carvykti Features

Figure 6. Others Features

Figure 7. Global BCMA-targeted CAR-T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global BCMA-targeted CAR-T Cell Therapy Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Oncology Clinic Case Studies

Figure 11. BCMA-targeted CAR-T Cell Therapy Report Years Considered

Figure 12. Global BCMA-targeted CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global BCMA-targeted CAR-T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global BCMA-targeted CAR-T Cell Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global BCMA-targeted CAR-T Cell Therapy Market Share by Players in 2024

Figure 16. Global BCMA-targeted CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by BCMA-targeted CAR-T Cell Therapy Revenue in 2024

Figure 18. North America BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America BCMA-targeted CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 20. United States BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe BCMA-targeted CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 24. Germany BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific BCMA-targeted CAR-T Cell Therapy Market Share by Region (2020-2031)

Figure 32. China BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America BCMA-targeted CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 40. Mexico BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa BCMA-targeted CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 44. Turkey BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE BCMA-targeted CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Nanjing Legend Biotechnology/J&J (Carvykti) Revenue Growth Rate in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

Figure 48. Bristol-Myers Squibb (Abecma) Revenue Growth Rate in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

Figure 49. CARsgen Revenue Growth Rate in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

Figure 50. Nanjing Iaso Biotherapeutics Revenue Growth Rate in BCMA-targeted CAR-T Cell Therapy Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Exosome Medical Technology Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14U12944

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Tumor Marker Detection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5A12294

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Hematological Malignancy Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J11325

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Personalized Cancer Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11F3068

Fri Mar 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions